Loading

Preparing for an IPO: Best Practices for Success

June 16, 2025
Breakout Session
Business Development and Investment
For biotech companies planning an IPO, navigating market dynamics, investor expectations, and regulatory hurdles is critical to success. This session brings together industry leaders to share insights on the evolving biotech IPO landscape, including current trends, valuation strategies, and capital market conditions. Panelists will discuss key factors in preparing for a public debut - optimal timing, market positioning, and crafting a compelling investor narrative. Drawing from recent IPO experiences, speakers will highlight common challenges, strategic considerations, and best practices for a smooth transition to the public markets. Whether attendees are in early planning stages or gearing up for an offering, this discussion will provide actionable insights to maximize IPO success.
Moderator
Kimberly Ha
CEO
KKH Advisors
Speakers
Jakob Dupont, MD
Executive Partner
Sofinnova Investments
Jennifer Fang
Partner
Wilson Sonsini
Andrew Lam, PharmD
Managing Director, Head of Biotech Private Equity
Ally Bridge Group
Jordan Saxe
Head of Healthcare Listings
NASDAQ
Chirag Surti
Exec Director
Morgan Stanley

BIO DOUBLE HELIX SPONSORS

Our sponsors help support BIO's mission to support and advocate for the biotechnology industry.

Loading

BIO HELIX SPONSORS